You are here

Article Text

Article menu
PDF
Recent advances in clinical practice
The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands
  1. Frank van Hees1,
  2. Ann G Zauber2,
  3. Harriët van Veldhuizen3,4,
  4. Marie-Louise A Heijnen4,
  5. Corine Penning1,
  6. Harry J de Koning1,
  7. Marjolein van Ballegooijen1,
  8. Iris Lansdorp-Vogelaar1
  1. 1Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
  2. 2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  3. 3Department of Quality Improvement, Erasmus MC, Rotterdam, The Netherlands
  4. 4National Institute for Public Health and the Environment, Bilthoven, The Netherlands
  1. Correspondence to Frank van Hees, Department of Public Health, Erasmus MC, P.O. Box 2040, Rotterdam 3000 CA, The Netherlands; f.vanhees{at}erasmusmc.nl

Abstract

In May 2011, the Dutch government decided to implement a national programme for colorectal cancer (CRC) screening using biennial faecal immunochemical test screening between ages 55 and 75. Decision modelling played an important role in informing this decision, as well as in the planning and implementation of the programme afterwards. In this overview, we illustrate the value of models in informing resource allocation in CRC screening using the role that decision modelling has played in the Dutch CRC screening programme as an example.

  • COLORECTAL CANCER SCREENING
  • COST-EFFECTIVENESS

http://dx.doi.org/10.1136/gutjnl-2015-309316

Statistics from Altmetric.com

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/